Health Care & Life Sciences » Biotechnology | Cytori Therapeutics Inc.

Cytori Therapeutics Inc. | Ownership

Companies that own Cytori Therapeutics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Swissquote Bank SA
376,723
4.88%
-156,100
84.85%
08/03/2018
Perkins Capital Management, Inc.
153,737
2%
-53,374
0.05%
06/30/2018
The Vanguard Group, Inc.
125,779
1.63%
65,104
0%
06/30/2018
Dimensional Fund Advisors LP
40,990
0.53%
40,990
0%
06/30/2018
Macquarie Funds Management Hong Kong Ltd.
40,182
0.52%
40,182
0%
06/30/2018
BlackRock Fund Advisors
24,242
0.32%
-6,864
0%
06/30/2018
Virtu Financial BD LLC
23,662
0.31%
9,322
0%
06/30/2018
Geode Capital Management LLC
16,630
0.22%
-2
0%
06/30/2018
Renaissance Technologies LLC
11,290
0.15%
11,290
0%
06/30/2018
Heights Capital Management, Inc.
6,657
0.09%
6,657
0%
12/31/2017

About Cytori Therapeutics

View Profile
Address
3020 Callan Road
San Diego California 92121
United States
Employees -
Website http://www.cytori.com
Updated 07/08/2019
Cytori Therapeutics, Inc. is a late stage cell therapy company which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions. It offers the Cytori Nanomedicine, Cytori Cell Therapy, and other clinical trials. The company was founded by Ralph E.